Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
PaperCitations, authors & open-access status
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,141 citations, 2019 year and bronze oa status.
1,141
Citations
2019
Year
bronze
OA Status